VARIANTS OF ADRENAL MYELOLIPOMAS AND RARE CONCOMITANT DISEASES

Cover Page


Cite item

Full Text

Abstract

Background: Adrenal myelolipoma is a rare tumor, etiology and pathogenesis of which aren’t completely defined. Intensified investigation of the tumor structural components in concomitant adrenal lesions and associated diseases enables more comprehensive discovery of its histogenesis features and more adequate assessment of the cause of different correlations between adipose and hemopoietic components of the tumor. Aim: Specification of the structural features of different variants of adrenal myelomas based on the analysis of the outcome of this tumor morphologic study including possible influence of associated diseases. Materials and methods: A total of 16 observations of adrenal myelolipomas are presented in the study including 11 “pure” tumors, 2 mixed (adenomas/myelolipomas), and 3 concurrent ones (adenoma and myelolipoma). Results: Correlation between hemopoietic elements and adipose tissue varies in both “pure” myelolipoma and combined adrenal tumor. Cavernous spleen hemangioma, accompanied by destruction of hemopoietic cells, gastrointestinal stromal tumor, and Hailey-Hailey disease, all based on genetic mutations, are rare concomitant diseases in adrenal myelolipoma. Conclusion: Myelolipoma tumorogenesis depends not only on concomitant pathology in adrenal gland but also on myelolipoma association with diseases stimulating histogenesis of both fatty cells and hemopoietic elements.

About the authors

G. A. Polyakova

Moscow Regional Research and Clinical Institute (MONIKI); 61/2 Shchepkina ul., Moscow, 129110, Russian Federation

Author for correspondence.
Email: galinapolyakova40@gmail.com
MD, PhD, Professor, senior scientific worker, Pathologoanatomy Department, MONIKI Россия

A. P. Kalinin

Moscow Regional Research and Clinical Institute (MONIKI); 61/2 Shchepkina ul., Moscow, 129110, Russian Federation

Email: fake@neicon.ru
Corr. member of RAS, MD, PhD, Professor, leading scientific worker, Department of Surgical Endocrinology, MONIKI Россия

References

  1. Дубова ЕА, Щеголев АИ, Кармазановский ГГ, Мишнев ОД, Косова ИА, Чебышева ЭН. Миелолипома надпочечника. Медицинская визуализация. 2006(1):22-8. (Dubova EA, Shchegolev AI, Karmazanovskiy GG, Mishnev OD, Kosova IA, Chebysheva EN. [Adrenal мyelolipoma]. Meditsinskaya vizualizatsiya. 2006;(1):22-8. Russian).
  2. Кузнецов НС, Бельцевич ДГ, Ванушко ВЭ, Солдатова ТВ, Ре- мизов ОВ, Кац ЛЕ, Лысенко МА. Дифференциальная диагностика инциденталом надпочечников. Эндокринная хирургия. 2011;(1):5-16. (Kuznetsov NS, Bel’tsevich DG, Vanushko VE, Soldatova TV, Remizov OV, Kats LE, Lysenko MA. [Differential diagnosis of adrenal incidentalomas]. Endokrinnaya khirurgiya. 2011;(1):5-16. Russian).
  3. Bishop E, Eble JN, Cheng L, Wang M, Chase DR, Orazi A, O’Malley DP. Adrenal myelolipomas show nonrandom X-chromosome inactivation in hematopoietic elements and fat: support for a clonal origin of myelolipomas. Am J Surg Pathol. 2006;30(7):838-43.
  4. Feng C, Jiang H, Ding Q, Wen H. Adrenal myelolipoma: a mingle of progenitor cells? Med Hypotheses. 2013;80(6):819-22.
  5. Daneshmand S, Quek ML. Adrenal myelolipoma: diagnosis and management. Urol J. 2006;3(2):71-4.
  6. Patel VG, Babalola OA, Fortson JK, Weaver WL. Adrenal myelolipoma: report of a case and review of the literature. Am Surg. 2006;72(7):649-54.
  7. Oliva A, Duarte B, Hammadeh R, Ghosh L, Baker RJ. Myelolipoma and endocrine dysfunction. Surgery. 1988;103(6):711-5.
  8. Sakaki M, Izaki H, Fukumori T, Taue R, Kishimoto T, Kanayama HO. Bilateral adrenal myelolipoma associated with adrenogenital syndrome. Int J Urol. 2006;13(6):801-2.
  9. Osborn M, Smith M, Senbanjo T, Crofton M, Robinson S, Rajan P. Adrenal myelolipoma - clinical, radiological and cytological findings: a case report. Cytopathology. 2002;13(4):242-6.
  10. Schaeffer EM, Kavoussi LR. Adrenal myelolipoma. J Urol. 2005;173(5):1760.
  11. Manassero F, Pomara G, Rappa F, Cuttano MG, Crisci A, Selli C. Adrenal myelolipoma associated with adenoma. Int J Urol. 2004;11(5):326-8.
  12. Al-Brahim N, Asa S. Myelolipoma with adrenocortical adenoma: an unusual combination that can resemble carcinoma. Endocr Pathol. 2007;18(2):103-5.
  13. Ong K, Tan KB, Putti TC. Myelolipoma within a non-functional adrenal cortical adenoma. Singapore Med J. 2007;48(7): e200-2.
  14. Sun X, Ayala A, Castro CY. Adrenocortical carcinoma with concomitant myelolipoma in a patient with hyperaldosteronism. Arch Pathol Lab Med. 2005;129(6):e144-7.
  15. Poiana C, Carsote M, Virtej I, Gruia A, Grgoriu C, Chirita C, Terzea D, Banceanu G. The adrenalectomy in rare endocrine tumors – 2 cases report. Jurnalul de Chirurgie, Iasi. 2010;6(1): 47-53.
  16. Казанцева ИА, Гуревич ЛЕ, Бобров МА. Патоморфологическая диагностика гастроинтестинальных стромальных опухолей. Цветной атлас. М.; 2013. (Kazantseva IA, Gurevich LE, Bobrov MA. Pathomorphologic diagnosis of gastrointestinal stromal tumors. Color atlas. Moscow; 2013. Russian).
  17. Кассирский ИА, Алексеев ГА. Клиническая гематология. М.: Медицина; 1970. (Kassirskiy IA, Alekseev GA. Clinical hematology. Moscow: Meditsina; 1970. Russian).
  18. Alexopoulos E, Kirmizis D, Visvardis G, Grollios G, Leontsini M, Memmos D. Focal segmental glomerulosclerosis in a patient with large bilateral asymptomatic adrenal myelolipomas. Ren Fail. 2003;25(6):1051-6.
  19. Richard G, Korge BP, Wright AR, Mazzanti C, Harth W, Annicchiarico-Petruzzelli M, Compton JG, Bale SJ. Hailey-Hailey disease maps to a 5 cM interval on chromosome 3q21-q24. J Invest Dermatol. 1995;105(3):357-60.
  20. Sudbrak R, Brown J, Dobson-Stone C, Carter S, Ramser J, White J, Healy E, Dissanayake M, Larrègue M, Perrussel M, Lehrach H, Munro CS, Strachan T, Burge S, Hovnanian A, Monaco AP. Hailey-Hailey disease is caused by mutations in ATP2C1 encoding a novel Ca(2+) pump. Hum Mol Genet. 2000;9(7):1131-40.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2014 Polyakova G.A., Kalinin A.P.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies